TYRA Tyra Biosciences, Inc.: institutional ownership and insider trading
177 funds reported holding $2.47B of Tyra Biosciences, Inc. in their latest 13F filings; in Q2 2026 funds net bought $93.7M, with 30 new positions and 24 funds selling out; over the last 12 months insiders bought $20.0K and sold $10.6M on the open market.
Famous investors holding TYRA
- Two Sigma (Two Sigma Investments): $14.4M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $8.89M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $6.47M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $645K, 0.0% of the portfolio
Largest institutional holders of TYRA
- RA CAPITAL MANAGEMENT, L.P. — $390M
- FMR LLC — $285M
- JANUS HENDERSON GROUP PLC (JHG) — $149M
- Jupiter Topco LLC — $139M
- Alta Partners Management Company, L.P. — $122M
- Nextech Invest, Ltd. — $114M
- TCG Crossover Management, LLC — $104M
- BlackRock, Inc. (BLK) — $96.8M
- PRICE T ROWE ASSOCIATES INC /MD/ — $88.9M
- STATE STREET CORP (STT, STT-PG) — $68.4M
Recent TYRA insider trades
- Sep 9, 2026: Verjee Rehan bought 972 shares ($20.0K)
- Mar 25, 2026: Kaplan Gilla sold 14,295 shares ($528K)
- Feb 12, 2026: Bensen Daniel sold 8,000 shares ($263K)
- Jan 12, 2026: Bensen Daniel sold 8,000 shares ($228K)
5%+ owners
- RA Capital Management, L.P.: 19.9% (Schedule 13D/A, filed Sep 17, 2026)
- FMR LLC: 14.4% (Schedule 13G, filed Apr 7, 2026)
- JANUS HENDERSON GROUP PLC: 7.2% (Schedule 13G/A, filed May 15, 2026)
- Dapice Joshua J.: 6.6% (Schedule 13G/A, filed May 12, 2026)
- BVF PARTNERS L P/IL: 6.1% (Schedule 13G, filed Sep 21, 2026)
- Nextech VI Oncology SCSp: 6.0% (Schedule 13G/A, filed Aug 14, 2026)